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Abstract
Background: Asthma and pregnancy are both sources of anxiety for women. Although there has been a focus on
physiological management of asthma and pregnancy, there has been little research on the impact that personalised
support can have on asthma care during pregnancy. This systematic review and narrative synthesis of the literature set
out to answer the question ‘What are women’s experiences of asthma care, its management and education, during
pregnancy?’
Methods: This systematic review was carried out using accepted methodology from the York Centre for
Reviews and Dissemination. Electronic database searches were conducted using PsycInfo, CINAHL, MedLine, Google
Scholar and the Cochrane Library, using the combination search terms: ‘Asthma’ AND ‘Pregnancy’ AND ‘Care’ AND
(‘Education OR Information OR Experience’). Hand searching of journals and searches for grey literature were also
undertaken. Independent quality appraisal by the three authors took place using the criteria detailed by Kmet et al.
(Standard Quality Assessment Criteria for Evaluating Primary Research Papers from a Variety of Fields, 2004).
Results: All papers scoring in excess of 60% were deemed to be of adequate quality for inclusion, of which there were
five: two qualitative designs and three quantitative designs. The designs were too methodologically heterogeneous to
permit statistical meta-analysis so narrative review and synthesis was undertaken. Despite an embryonic evidence bases,
it is reasonable to conclude that personalised care has beneficial outcomes for pregnant asthmatic women.
Conclusions: Larger randomised controlled trials investigating personalised care are required to build an evidence base
which can establish the efficacy of such interventions.
Keywords: Asthma, Pregnancy, Care, Support, Experiences
Background
Pregnancy can be a worrying time for women, and it is
common that prospective mothers are anxious about the
health of their child and about the birth itself; these wor-
ries are quite distinct from generalised anxiety and can
manifest in prolonged mood disturbances which do not
simply resolve after delivery [1]. In addition to these
fears about pregnancy itself, pregnant women with
asthma have an additional substantial health issue to
worry about in their asthma. It is known that psycho-
logical morbidity including depression is in itself a
predisposing factor for asthma exacerbations, and more
specifically that anxiety is a cause of exacerbations in
pregnant women [2]. This is compounded by the fact
that during pregnancy, one third of pregnant asthma
suffers’ asthma will worsen, one third’s will stay the
same, and one third’s will improve and there seems to be
little or no way of predicting accurately which individ-
uals will be adversely affected [3].
Pregnant women with asthma are more likely to suffer
pre-eclampsia than women without asthma, but if
asthma is left uncontrolled, pregnancy complications
can include hyperemesis, hypertension, pre-eclampsia,
vaginal haemorrhage, complicated labour, fetal growth
restriction, pre-term birth, increased perinatal mortality,
neonatal hypoxia, and possibly increased Caesarean
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section risk [3]. United Kingdom guidance regarding the
management of asthma and pregnancy [3] is that preg-
nant women with more than mild asthma should be
monitored closely to make sure that their asthma is well
controlled, which significantly reduces the risks of these
pregnancy-related complications. As well as potential
risks to their own health, pregnant women are likely to
worry about the risks of their asthma and its treatments
to their unborn baby, and to their new-born when
breastfeeding. Guidance indicates that women should re-
ceive advice about maintaining good control of their
asthma during pregnancy to avoid risks for mother and
baby, and that B2 agonists, and oral and inhaled cortico-
steroids and other medications should be maintained
where necessary during pregnancy [3]. European pre-
scribing practice is reasonably consistent [4] with uni-
form peaks in prescribing for pregnant asthmatics in the
second trimester (when exacerbations are likely to
occur) and then a decline in the three months after
birth. However, analysing the rates of prescribing and
dispensing of medications says nothing about whether
the women to whom they are prescribed understood
what they were taking and why, or how worried they
might have been when ingesting them.
Pregnant women are more likely to seek health advice
and support for their asthma when they are pregnant
than for many other aspects of pregnancy, particularly if
they are of low income and in their first pregnancy [5].
Targeted health education and advice can have positive
benefits for recipients in terms of confidence [6]. Self-
management strategies can be beneficial [7, 8] but no
single strategy is likely to suit all individuals [9]. Deter-
mining the extent to which such advice is delivered to
pregnant asthmatic women is problematic. A recent sys-
tematic review of asthma care implementation interven-
tions found that asthma self-management remains poorly
implemented in clinical practice despite overwhelming
evidence that asthma outcomes are improved [10], and
despite guideline recommendations spanning thirty years.
There is inconsistent knowledge and understanding of
asthma and pregnancy amongst some midwives [11] who
would routinely be in contact with pregnant women more
often than other health professionals.
There is a wealth of research about managing physio-
logical aspects of asthma and pregnancy including pharma-
cological interventions [12], and non-pharmacological
interventions including education, progressive muscle re-
laxation and Fraction of Exhaled Nitric Oxide have also
been researched, although the evidence base needs larger,
high quality trials before results can be described as defini-
tive [13]. However, there is a paucity of research examining
pregnant asthmatic women’s experiences of their care, or
the influence that healthcare professionals such as nurses
and midwives can make, despite evidence that women’s
asthma care in pregnancy is variable [14]. In order to ex-
plore these issues, we conducted this systematic review,
the aim of which is to answer the question ‘What are
women’s experiences of asthma care, its management and
education, during pregnancy?’
Methods
Design
This systematic review followed the method set out by
the Centre for Reviews and Dissemination [15], using
specific search terms for database searches, inclusion
and exclusion criteria and quality appraisal of relevant
papers. In addition, we hand-searched references and
also used Google Scholar to identify any other relevant
papers. Types of study design to be included in the re-
view were (see Table 1) empirical studies of any design,
systematic reviews and framework/development studies.
Exclusion criteria were: papers that were not published
in English; not about education or informational care;
were regarding children and their experiences or were
experiences of healthcare professionals.
Search strategy
All searches took place in May 2016 and sought to iden-
tify peer reviewed articles published in English, between
January 2003 and May 2016 (see Table 2 for the search
results). A start date of 2003 was chosen as it was the
date of publication of the first BTS/SIGN guideline. The
electronic databases used were PsycInfo, CINAHL, Med-
Line and Google Scholar and the Cochrane Library,
using the following combination of search terms:
‘Asthma’ AND ‘Pregnancy’ AND ‘Care’ AND (‘Education
OR Information OR Experience’) with these last terms
bracketed together as a concept.
In an attempt to uncover grey literature, three further
databases were searched using the key words ‘asthma
and pregnancy’ and addressing the inclusion and exclu-
sion criteria. Firstly, the PROSPERO database for
Table 1 Inclusion and Exclusion criteria applied to systematic
review papers
Inclusion criteria Exclusion criteria
Papers published between 2003 and
2016
Papers not published in English
Children and their experiences
Adult females over 16 years of age
with diagnosis of asthma
Experiences of healthcare
professionals
Not a systematic literature review/
research study
Women who have undergone
pregnancy
Not about education or
informational care
Letters/editorials/conference
papers
Low KMET score
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systematic review protocols was searched but this search
revealed no registered systematic review protocols on
the topic. Secondly, a search of the clinical trials registry
www.clinicaltrials.gov (a service provided by the US
National Institutes of Health) revealed two relevant
studies, however of these two, one was suspended and
the second was completed in 2013 but showed no re-
sults posted in the register and a corresponding full art-
icle was not found during the more detailed search.
Thirdly, the EU Clinical Trials Register (www. www.cli-
nicaltrialsregister.eu) which contains registrations of tri-
als to be conducted in the European Union (EU) or
linked to the EU territories also revealed no relevant re-
sults. Therefore, the searches from PROSPERO, Clinical-
trials.gov and the EU Clinical Trials Register have not
been included in the analysis.
From the electronic databases that did produce results,
239 papers were identified with a further nine from
additional sources. Figure 1 illustrates the process and is a
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) flow diagram. A total of 11 du-
plicates were then identified and removed, leaving 237 pa-
pers to be reviewed. After screening the titles/abstracts of
these papers and applying the search inclusion and exclu-
sion criteria to determine eligibility, a further 196 papers
were excluded. The remaining 41 full articles were read in
full, with an additional 34 being excluded as they did not
meet the inclusion criteria or were not relevant.
Quality appraisal
All papers were assessed using the quality appraisal tool
for qualitative and quantitative research, as described by
Table 2 Number of papers identified through searching electronic databases
2003-2016 In English Search terms: Medline CINAHL (excluding
Medline records)
PsycInfo Cochrane
Library
Google Scholar/
Research Gate
Asthma + Pregnancy + Care + (Education OR Information OR Experience) 106 31 22 80 9
Fig. 1 PRISMA
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Kmet et al. [16]. Of the initial seven papers that were
subjected to this quality appraisal, one was excluded due
to lack of relevance [17] and one was excluded due to a
low quality appraisal score and not being a research
study [18], resulting in a total of five papers being in-
cluded in the review. The three review authors assessed
the papers independently and then compared and
agreed scores. Where there were discrepancies in
scoring, this was resolved through discussion until a
consensus was reached.
Results
The final papers included in the review consisted of two
qualitative papers (see Table 3) that scored 90% [19] and
100% [14] respectively, and three quantitative papers
(see Table 4) with scores ranging between 86 and 96%.
The authors decided to include all papers scoring 60%
or above, with only two papers in the initial assessment
process not meeting this quality standard. All papers
scoring in excess of 60% were deemed to be of adequate
quality for inclusion within the review and a summary of
these papers can be found in Table 5.
Certain methodological features usually associated
with systematic reviews have not been possible to assess
in this study [20]. Assessment of heterogeneity in the re-
sults of systematic reviews is important because it indi-
cates whether in fact the studies to be included in the
review are similar enough for that combination to be
meaningful. Inevitably, study variables, units of measure-
ment and outcomes will be dissimilar, but the extent of
that difference should be assessed statistically where
possible when meta-analysis using odds ratios is
intended [21]. The results of this systematic review are
methodologically diverse, meaning that they are too het-
erogeneous in study designs for their outcomes to be
combined in statistical meta-analysis and the papers are
therefore evaluated and discussed below in a narrative
review, beginning with those from qualitative designs
and moving on to the quantitative designs. This hetero-
geneity, combined with a near-absence of randomised
controlled trials, means that it has not been possible
to estimate publication bias or produce funnel plots
to analyse it; however, we have no reason to believe
that publication bias is a significant issue in this re-
view or indeed that it would alter the analysis and
synthesis of studies, because publication bias is most
important if it influences the interpretation and direc-
tion of effect sizes in meta-analysis, which this sys-
tematic review is not able to do [20].
Discussion
Qualitative designs
Lim et al. [19] and Chamberlain et al. [14] conducted
interview-based qualitative research with purposive sam-
ples of women (23 and seven participants respectively).
Chamberlain et al. [14] interviewed women who had de-
livered their babies within two years of the interview,
using ‘Framework Analysis’ to construct themes from
the qualitative data they recorded. Key findings were
themes related to women’s experiences of Asthma and
pregnancy, which were largely concerning their experi-
ences of illness and related physical health anxieties;
Pregnancy and post-natal experiences, where they re-
lated concerns about their asthma and its potential im-
pact on their baby; and Health professionals, in which
the women discussed mostly negative experiences with
health professionals. The major limitations of this study
[14] concern the extent of women’s symptoms, in that
they did not objectively measure asthma symptoms
using a valid and reliable scale such as the Asthma Con-
trol Questionnaire (ACQ), but instead relied on ‘a con-
firmed diagnosis of asthma’ as their diagnostic
categorisation. A further limitation concerns the inter-
pretation of findings, in that participants in Chamberlain
et al’s study [14] may have had an element of recall
based on the length of time since delivery (which is not
reported for participants), although it is not clear if that
might lead them to over-or under-represent their
experiences.
Lim et al. [19] recruited a purposive sample from one
Australian hospital (derived from 179 potential partici-
pants) of n = 23 asthmatic women who were still preg-
nant, either primi- or multi-gravid, as well as newly
delivered within five weeks, and sought to investigate
how pregnant women manage their asthma during preg-
nancy. They conducted in-depth interviews (18 by
Table 3 Quality appraisal scores for Qualitative Studies
Papers Chamberlain
et al. 2014 [14]
Lim et al.
2012 [19]
Question/objective sufficiently
described?
2 2
Study design evident and appropriate? 2 2
Context for the study clear? 2 2
Connection to a theoretical framework/
wider body of knowledge?
2 2
Sampling strategy described, relevant
and justified?
2 2
Data collection methods clearly
described and systematic?
2 2
Data analysis clearly described and
systematic?
2 2
Use of verification procedure(s) to
establish credibility?
2 2
Conclusions supported by the results? 2 2
Reflexivity of the account? 2 0
Summary score 1.00 0.90
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telephone and 5 face-to-face) with pregnant asthmatic
women, which were again coded using the ‘Framework
approach’. Five major themes relating to asthma man-
agement during pregnancy and changes in behaviour
emerged: Risks versus Benefits, Self-Efficacy, Asthma as a
Priority, Support and Guidance and Influences on Medi-
cation Use. Asthma monitoring during pregnancy was
seen as a low priority for some women and their doctors.
Communication between pregnant women and health
professionals regarding asthma management was poor.
Arguably Lim et al. [19] were not comparing the per-
spectives of a similar enough sample by recruiting from
across the course of pregnancy and delivery, however
they were accurate in their assessment of symptoms,
using the ACQ to assess their participants’ symptoms.
The largest potential methodological weakness of Lim et
al. [19] is the lack of explicit discussion of rigour and re-
flexivity in their account, although this is a compara-
tively minor point of critical analysis in an otherwise
robust qualitative design.
Despite these differences in recruitment and classifica-
tion, both qualitative studies produced similar themes
and, in some areas, overlapping findings. It is striking
that participants in both studies talked about their fears
explicitly and this centred on medications, particularly
steroids. In both studies, the women reported worry
about risks versus benefits to their health and that of
their babies of taking their medications, with some
women in Lim et al’s study [19] unilaterally reducing
their medications without reference to health care pro-
fessionals. Participants in both studies talked about their
desire for self-management, but most were unaware that
their asthma might worsen in pregnancy and were un-
prepared for that. Most wanted ‘more’ education with
little focus on community sector health care personnel
including midwives and general practitioners. Lim et al’s
study [19] indicated that women used the internet for
information, but this was not discussed by Chamberlain
et al’s [14] participants. As Lim et al. [19] was conducted
in Australia and Chamberlain et al. [14] was conducted
in England, these two papers indicate that these issues
are not restricted to one location.
Quantitative designs
Two of the quantitative papers [22, 23] were quasi-
experimental designs with pre-and post-tests applied to
non-randomised groups of pregnant asthmatic women.
Murphy et al. [22] recruited 211 participants with di-
agnosed asthma who were also pregnant, who were then
assessed by a specialist nurse at 20 weeks’ gestation and
then followed up at 33 weeks’ gestation by the same
nurse. As part of these assessments, an information ses-
sion consisting of history taking, self-management skills,
medications adherence and knowledge, and further
Table 4 Quality appraisal scores for Quantitative Studies
Papers Grzeskowiak et al. 2016 [23] Lim et al. 2014 [26] Murphy et al. 2005 [22]
Question/objective sufficiently described? 2 2 2
Study design evident and appropriate? 2 2 2
Method of subject/comparison group selection
or source of information/input variables described
and appropriate?
1 2 1
Subject (and comparison group, if applicable)
characteristics sufficiently described?
2 2 2
If interventional and random allocation was
possible, was it described?
N/A 2 N/A
If interventional and blinding of investigators
was possible, was it reported?
N/A 1 N/A
If interventional and blinding of subjects was
possible, was it reported?
N/A 2 N/A
Outcome and (if applicable) exposure measure(s)
well defined and robust to measurement/
misclassification bias? Means of assessment reported?
2 2 2
Sample size appropriate? 2 2 2
Analytic methods described/justified and appropriate? 2 2 2
Some estimate of variance is reported for the main results? 2 2 2
Controlled for confounding? 0 2 1
Results reported in sufficient detail? 2 2 2
Conclusions supported by the results? 2 2 2
Summary score 0.86 0.96 0.91
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education was given to participants, contributing to a
written action plan. Peak Flow (PEF) self-measurement
and Forced Expiratory Volume at one second (FEV1)
were recorded and urgent medical review was secured
where necessary. Murphy et al. [22] report that at first
visit, the women had poor self-management skills, 40%
non-adherence to inhaled corticosteroids and little un-
derstanding of medications. Only 3% were taking their
own PEF. After the session with the specialist nurse, all
of these metrics were substantially improved with
women who remained in the study. Specifically, those
who received a written asthma action plan (WAAP) had
babies with statistically significantly higher birth weight
than those who did not.
The major strength of a quasi-experimental study de-
sign with pre-and post-tests lies in its pragmatism as it
explores important concepts in real-world situations.
Limitations in Murphy et al’s [22] study design include
that pre-post-test designs do not eliminate Hawthorne
effects and are potentially open to investigator bias via
recruitment and selection. Also, there is likely to be a
significant maturation effect (where test scores improve
as a result of time passing and participants developing in
some way) which is a potential source of threat to in-
ternal validity, casting doubt over the credibility of such
study designs as evidence for efficacy of treatment ef-
fects [24, 25]. and despite the issues with Hawthorne ef-
fects, potential sources of bias and threats to internal
validity [24, 25] noted above, it is clear that their inter-
vention, involving contact and care from a specialist
nurse, made clinically important differences to their
women and babies, and that this was particularly the
case for those most severely asthmatic during their
pregnancy.
In a similar design to that of Murphy et al. [22],
Grezeskowiak et al. [23] recruited 169 pregnant women
with diagnosed asthma. These women were assessed at
four points during their pregnancy by a midwife with
additional respiratory training for demographic variables
including socio-economic status as well as asthma-
related ones including medications, control of symptoms
(using the Asthma Control Questionnaire, ACQ), use of
corticosteroids and hospital admissions. FEV1 was re-
corded. Half way through the study a new antenatal
asthma service was introduced which was led by a re-
spiratory nurse, meaning that the women received ses-
sions on managing asthma in pregnancy based on
evidence-based guidelines. Outcomes were assessed for
the 89 women who received standard care and to 80
who attended the new service. Similar to Murphy et al’s
study [23], Grezeskowiak et al. [23] found that those
who attended the new antenatal asthma and pregnancy
service, involving contact and care from a specialist
nurse, were statistically significantly less likely to have a
loss of asthma control or persistent symptoms during
their pregnancy. There was an increase in smoking ces-
sation amongst those in the intervention group
compared to the control group, as the asthma manage-
ment nurses were trained to provide advice on how to
stop smoking. Perinatal outcomes were the same but
there was a non-statistically significant reduction in pre-
term births and Caesarean sections in those attending
the new service. Indeed, several variables were non-
statistically significant; for example, there was no di-
fference in the reduction of exacerbations in moderate/
severe asthma between the two groups, indicating that,
as well as the criticisms of quasi-experimental pre-post-
tests designs discussed above [24, 25], Grezeskowiak et
al’s [23] study was underpowered and the authors ac-
knowledge this. Study power is important because it is
difficult to assess whether the non-significant results are
genuine or are type II errors (false negatives) resulting
from small sample size [25], which is a potential threat
to the external validity of this study.
Despite the limitations noted in both the quasi-
experimental designs [22, 23] Grezeskowiak et al’s [23]
results support those of Murphy et al. [22], indicating
that targeted intervention involving contact and care
from a specialist nurse can make a difference in clinical
outcomes. Grezeskowiak et al. [23] speculate that the
asthma management nurses provided a continuity of
care which is particularly valuable for women at the
lower end of the socio-economic scale, as these women
are generally more likely to fare badly in many preg-
nancy outcomes including vaginal delivery, pre-term de-
livery and miscarriage.
Lim et al. [26] conducted the only randomised con-
trolled trial retrieved in our systematic review, which in-
cluded pregnant women up to 20 weeks’ gestation who
had asthma symptoms within the last 12 months. Partic-
ipants were assessed for severity of symptoms and then
randomised into mild to intermittent or moderate to se-
vere asthma symptom groups, and within each group
block randomisation was applied to allocate participants
to either usual care (control) group or multidisciplinary
care (intervention) group. The intervention was a Multi-
disciplinary Approach to the Management of Maternal
Asthma (MAMMA©) and included education, monitor-
ing, feedback and follow-up on a monthly basis, includ-
ing assessment using FEV1 and the ACQ. The
intervention consisted of regular contact, advice and
medication review by a pharmacist, who referred women
with worsening asthma to a family physician for further
review and support. Comparison of the ACQ scores at 3
and 6 months were the primary variables, and secondary
variables were asthma exacerbations, hospital admis-
sions, time off work, oral steroid use and neonatal out-
comes (the latter obtained from obstetric notes). An 80%
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power to detect a ACQ score of >0.5 would be achieved
with 29 participants. Lim et al. [26] recruited 60 in total
and found that 70% of participants did not realise the
importance of good asthma control at the start of the
trial and 19 had reduced or stopped their medications
because they had become pregnant. In the intervention
group, the ACQ score reduced at 3 and 6 months, al-
though it was only statistically significant at 6 months,
and all the scores in the intervention group indicated ad-
equate asthma control. Perinatal outcomes were the
same for intervention and control groups.
Their trial was adequately powered, and Lim et al. [26]
applied intention to treat analysis (ITT) for drop outs,
meaning that missing patients’ data was not omitted
from the study, which might otherwise undermine the
theoretical basis for statistical analysis and is a source of
bias towards favourable outcomes [27, 28]. As a single-
blinded study, one potential criticism is that the Haw-
thorne effect may bias outcomes, and this has been
shown to be a particularly significant issue in studies
where participants in the intervention group receive
additional follow up compared to those in the control
group [28]. However, in order to conduct research of
this nature in the ‘real world’ a pragmatic approach is re-
quired [29], and so it would not have been possible for
Lim et al. [26] to double blind participants concerning
their group allocation. Furthermore, data collection and
analysis were undertaken by blinded independent re-
searchers, meaning that group allocation was concealed
to avoid bias.
Synthesis, hierarchy of evidence and clinical effectiveness
It is clear from the results of this systematic review and
narrative summary that a very important factor in secur-
ing beneficial outcomes for pregnant asthmatic women
is targeted support from a dedicated healthcare profes-
sional who is able to help women with management and
self-management. Personalised contact featured in all
five of the studies reported here: in the two qualitative
designs [14, 19] it was described as important but lack-
ing, whilst the three quantitative designs [22, 23, 26]
gave positive evidence concerning the beneficial impact
that could be achieved with targeted input and personal
contact. These quantitative designs [22, 23, 26] are par-
ticularly important in this regard as they have quantified a
range of clinically and statistically important benefits ac-
cruing from dedicated asthma care including improve-
ments in asthma symptoms measured by ACQ scores,
pre-term births, birth weight and Caesarean section rates.
However, synthesising and interpreting the results of
this systematic review is highly tentative. The purpose of
a hierarchy of evidence is to evaluate the strength of
evidence in relation to clinical effectiveness [30]. Ac-
cepted hierarchies are diagrammatically pyramidal and
graduated with systematic reviews and meta-analyses as
the most effective designs, randomised controlled trials
(RCTs) second, with other quantitative designs and then
qualitative designs as progressively less effective guides
for clinical decision making. The five papers reviewed in
this study are methodologically heterogeneous. Lim et al.
[26] is an RCT, and so sits highest in traditional hier-
archies of evidence, but even so it is single blinded only
and a weaker design to RCTs that are double blinded
and can more fully control potential biases [30]. The be-
fore and after studies [22, 23] are weaker designs still,
with concerns about internal validity accruing from po-
tential Hawthorne and maturation effects as well as in-
vestigator biases [24]. Lim et al. [19] and Chamberlain et
al. [14] are qualitative designs that, although robust in
that paradigm, are likely to continue to be regarded as
poor evidence for clinical effectiveness despite efforts to
explore and delineate qualitative designs as evidence for
practice [31].
In summary, the evidence base concerning persona-
lised care for pregnant asthmatic women can best be de-
scribed as embryonic and further research is required to
discover the best strategies for helping them to self-
manage their asthma. This makes it difficult to offer firm
recommendations for clinical practice as a result of this
systematic review and narrative synthesis, however, it
seems reasonable to suggest that personalised care and
contact with healthcare professionals can have beneficial
outcomes, and this has been established in community
settings [32, 33]. This recommendation would rank as
‘weak’ according to GRADE classification [34] but our
‘weak’ findings complement the ‘strong’ recommenda-
tions made in clinical guidelines that women should re-
ceive advice about the importance of maintaining good
asthma control during pregnancy to avoid problems for
mother and baby, and that pregnant women with mod-
erate/severe asthma should be closely monitored to keep
their asthma well controlled [3].
Recommendations for future research
It seems clear from this systematic review that pregnant
women with asthma need additional support and care
relating to their asthma. The papers reviewed here indi-
cate that contact with a dedicated healthcare profes-
sional can facilitate that, and further research is required
to examine this area, with larger trials that establish
whether or not there is any ‘added value’ in personalised
support for pregnant women with asthma, over and
above any gains that might be made from different
therapeutic regimes and/or asthma control monitoring
using Fraction of Exhaled Nitric Oxide, particular as this
latter monitoring option is not necessarily diagnostic [3].
Authoritative guidelines recommend this level of de-
tailed and personalised response from health care
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professionals [3], but if resources or practitioner confi-
dence do not permit such close intervention in the com-
munity [35] telehealth solutions might provide a method
to combine asynchronous information access and im-
prove self-efficacy [36]. Although the role of telehealth
in asthma has been evaluated in a Cochrane systematic
review and found not to result in clinically important
improvements in asthma quality of life in mildly asth-
matic people, telehealth interventions are useful in those
with severe disease at high risk of hospital admission
[36], and also to be effective in reducing anxiety and im-
proving quality of life in patients with Chronic Obstruct-
ive Pulmonary Disease [37]. Furthermore, when
specifically targeted at pregnant asthmatic women, tele-
health has proved much more successful: where partici-
pants were offered personal written asthma action plans,
a smart-phone application (app) and a hand-held spir-
ometer, there were statistically significant improvements
in asthma quality of life as measured using the ACQ
[38]. This type of service delivery has the advantage of
involving participants in self-monitoring and disease
regulation, particularly when made gender-specific and
acknowledging hormonal variations [39] as would be the
case for pregnant women. Pregnant asthmatic women
already use the internet for information [40] and it is
therefore reasonable to assume that a structured ap-
proach would be beneficial, but this requires appropriate
scientific analysis. One recommendation for further re-
search, therefore, is to examine the role of telehealth in
provision of information to pregnant asthmatic women.
More specifically, there could be benefits in the
provision of resources that are available asynchronously
for personal consultation by women at times convenient
to them, as an adjunct to WAAPs, rather than relying
on timetabled contact during ‘office hours’ with dedi-
cated professionals. One systematic review [40] found
consistent evidence suggesting that asynchronous tele-
health lead to shorter waiting times, fewer unnecessary
referrals, high patient satisfaction, and no lesser diagnos-
tic accuracy when compared with face-to-face consulta-
tions. This asynchronicity has been found to be
particularly important in paediatric asthma, where emer-
gency admissions were avoided and satisfaction with the
resources was high [41] and substantial costs savings in
remote locations [42]. Such asynchronous resources
could act as an information repository to provide re-
assurance and guidance about important aspects of
asthma care including symptom control and medica-
tions, and might help pregnant women to be more
confident about when to contact health professionals
and then to get more out of their consultations with
them. This might be particularly useful as women in
pregnancy are uniquely receptive to educational input,
already access the internet for information [40]. Clearly
the internet offers a means for social support which is
accessible from within the home 24 h a day, and has
already been shown to be effective in supporting preg-
nancy, including in reducing anxiety [43].
Conclusions
We found an embryonic evidence base concerning the
benefits of personalised support, with only five papers
that meet our inclusion and exclusion criteria and qual-
ity assessment scoring [16]. Whilst the standing of this
evidence base is low in relation to accepted hierarchies
of evidence, and the strength of our recommendations
consequently weak [34], they support the authoritative
guidance [3] that pregnant asthmatic women should re-
ceive monitoring and advice which helps them to under-
stand their asthma symptoms and the role that their
medications play in controlling them, including inhaled
B2 agonists, and oral and inhaled corticosteroids. Larger
randomised controlled trials investigating personalised
care are required to build an evidence base to establish
the efficacy of such interventions.
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